Citius Pharmaceuticals Inc (CTXR) concluded trading on Thursday at a closing price of $0.81, with 6.32 million shares of worth about $5.12 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 9.73% during that period and on April 18, 2024 the price saw a loss of about -1.31%. Currently the company’s common shares owned by public are about 158.86M shares, out of which, 146.79M shares are available for trading.
Stock saw a price change of -3.32% in past 5 days and over the past one month there was a price change of 8.43%. Year-to-date (YTD), CTXR shares are showing a performance of 6.48% which decreased to -51.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.60 but also hit the highest price of $1.70 during that period. The average intraday trading volume for Citius Pharmaceuticals Inc shares is 751.18K. The stock is currently trading -6.40% below its 20-day simple moving average (SMA20), while that difference is up 2.92% for SMA50 and it goes to -1.65% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Citius Pharmaceuticals Inc (NASDAQ: CTXR) currently have 158.86M outstanding shares and institutions hold larger chunk of about 16.96% of that.
The stock has a current market capitalization of $128.15M and its 3Y-monthly beta is at 1.52. It has posted earnings per share of -$0.26 in the same period. It has Quick Ratio of 5.06 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CTXR, volatility over the week remained 12.90% while standing at 11.19% over the month.
Analysts are in expectations that Citius Pharmaceuticals Inc (CTXR) stock would likely to be making an EPS of $Charles & Colvard Ltd. in the current quarter, while forecast for next quarter EPS is $0.34 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $ClearBridge MLP and Midstream T which is $WEST TEXAS RESOURCES INC at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $CTXS in the same quarter a year ago.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on November 30, 2021 offering a Buy rating for the stock and assigned a target price of $4 to it.
